Zhang Financial’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$131K Buy
111,900
+12,000
+12% +$17K ﹤0.01% 361
2025
Q4
$149K Buy
99,900
+15,700
+19% +$28.2K 0.01% 335
2025
Q3
$182K Sell
84,200
-5,560
-6% -$10.3K 0.01% 312
2025
Q2
$142K Sell
89,760
-6,500
-7% -$8.69K 0.01% 286
2025
Q1
$104K Buy
96,260
+3,073
+3% +$3K 0.01% 297
2024
Q4
$64.9K Buy
93,187
+23,800
+34% +$22K ﹤0.01% 294
2024
Q3
$66.6K Buy
69,387
+13,500
+24% +$13.6K ﹤0.01% 276
2024
Q2
$51.4K Buy
55,887
+3,827
+7% +$2.79K ﹤0.01% 267
2024
Q1
$23.6K Hold
52,060
﹤0.01% 266
2023
Q4
$29.2K Buy
52,060
+1,500
+3% +$946 ﹤0.01% 253
2023
Q3
$33.4K Buy
50,560
+5,500
+12% +$3.79K ﹤0.01% 230
2023
Q2
$30.7K Buy
45,060
+17,100
+61% +$14.5K ﹤0.01% 245
2023
Q1
$30.5K Buy
27,960
+7,260
+35% +$4.75K ﹤0.01% 227
2022
Q4
$12.4K Hold
20,700
﹤0.01% 226
2022
Q3
$16K Buy
20,700
+1,500
+8% +$1.13K ﹤0.01% 216
2022
Q2
$14K Buy
+19,200
New +$16.5K ﹤0.01% 215

Other funds holding TLSA

Zhang Financial's TLSA Position: Q1 2026 in Review

Zhang Financial increased its Tiziana Life Sciences (TLSA) stake by 12% in Q1 2026, buying an estimated $17K and bringing the position to 111,900 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #361.

Zhang Financial first reported a position in TLSA in Q2 2022 and has held it in 16 quarters since. The position peaked at $182K in Q3 2025. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2026.

  • Zhang Financial held 111,900 shares of Tiziana Life Sciences worth $131K as of Q1 2026.
  • Zhang Financial bought 12,000 Tiziana Life Sciences shares in Q1 2026, an estimated $17K.
  • Tiziana Life Sciences made up ﹤0.01% of Zhang Financial's portfolio in Q1 2026, its #361 holding.
  • Zhang Financial first reported a position in Tiziana Life Sciences in Q2 2022 and has held it in 16 quarters since.
  • Zhang Financial's Tiziana Life Sciences position peaked at $182K in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2026.

Based on Zhang Financial's 13F filing for Q1 2026, filed 6 May 2026.